Vimarsana
Biggest News Aggregation in the World

Page 12 - Mindset Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mindset Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mindset Pharma Today - Breaking & Trending Today

The Power Play by The Market Herald Interviews James Lanthier of Mindset Pharma - Vimarsana News

The Power Play by The Market Herald Interviews James Lanthier of Mindset Pharma

VANCOUVER, BC / ACCESSWIRE / January 5, 2022 / The Power Play by The Market Herald has announced the release of a new interview with Mindset Pharma on their latest news.The Power Play by The Market Herald

TikTok Self-Diagnoses; COVID Depression for Older Adults; Fitbit Screening Bipolar? - Vimarsana News

TikTok Self-Diagnoses; COVID Depression for Older Adults; Fitbit Screening Bipolar?

News and commentary from the psychiatry world

Mindset Pharma Inc. files international patent application covering its Family 3 psychedelic compounds - Vimarsana News

Mindset Pharma Inc. files international patent application covering its Family 3 psychedelic compounds

Chief Scientific Officer Joseph Araujo said 'such compounds may be optimal for indications in which a long-term, micro-dosing, paradigm is...

Canadian Securities Exchange (CSE): Canadian Securities Exchange's November 2021 Performance Includes Strong Listings Growth and New Financing Milestone - Vimarsana News

Canadian Securities Exchange (CSE): Canadian Securities Exchange's November 2021 Performance Includes Strong Listings Growth and New Financing Milestone

Toronto, Ontario--(Newsfile Corp. - December 15, 2021) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced its market statistics for the month of November 2021, which was highlighted

HC Wainright & Co starts coverage on Mindset Pharma Inc with a Buy rating and C$5 price target - Vimarsana News

HC Wainright & Co starts coverage on Mindset Pharma Inc with a Buy rating and C$5 price target

The research group wrote that Toronto-based Mindset is “pioneering the next generation of psychedelic-enhanced therapies"